- Home
- FONR vs MNOV Comparison
FONR vs MNOV Comparison
Compare FONR & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FONR
- MNOV
- Stock Information
- Founded
- FONR 1978
- MNOV 2000
- Country
- FONR United States
- MNOV United States
- Employees
- FONR N/A
- MNOV N/A
- Industry
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- FONR Health Care
- MNOV Health Care
- Exchange
- FONR Nasdaq
- MNOV Nasdaq
- Market Cap
- FONR 100.2M
- MNOV 89.8M
- IPO Year
- FONR 1987
- MNOV 2005
- Fundamental
- Price
- FONR $14.75
- MNOV $1.83
- Analyst Decision
- FONR
- MNOV Strong Buy
- Analyst Count
- FONR 0
- MNOV 1
- Target Price
- FONR N/A
- MNOV $9.00
- AVG Volume (30 Days)
- FONR 17.9K
- MNOV 21.3K
- Earning Date
- FONR 02-18-2025
- MNOV 02-19-2025
- Dividend Yield
- FONR N/A
- MNOV N/A
- EPS Growth
- FONR N/A
- MNOV N/A
- EPS
- FONR 1.17
- MNOV N/A
- Revenue
- FONR $101,570,089.00
- MNOV N/A
- Revenue This Year
- FONR N/A
- MNOV N/A
- Revenue Next Year
- FONR N/A
- MNOV N/A
- P/E Ratio
- FONR $12.56
- MNOV N/A
- Revenue Growth
- FONR N/A
- MNOV N/A
- 52 Week Low
- FONR $14.05
- MNOV $1.12
- 52 Week High
- FONR $23.41
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- FONR 37.71
- MNOV 43.26
- Support Level
- FONR $14.63
- MNOV $1.75
- Resistance Level
- FONR $17.62
- MNOV $2.00
- Average True Range (ATR)
- FONR 0.53
- MNOV 0.08
- MACD
- FONR -0.16
- MNOV -0.00
- Stochastic Oscillator
- FONR 4.03
- MNOV 27.59
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.